Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

605
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
605
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

111
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
111
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.4K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.4K
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

128
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
128
Aging01:26

Aging

476
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
476
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

110
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
110

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient and oncologist expectations of functional prognosis among older adults with acute myeloid leukemia.

Blood advances·2026
Same author

Corrigendum to 'An electronic geriatric assessment platform (eGAP) for older patients with cancer' [Journal of Geriatric Oncology 17(4) (2026) 102966].

Journal of geriatric oncology·2026
Same author

Developing a Novel Values Elicitation Measure for Clinical Use in Older Adults with Hematologic Malignancies: Values-HM.

MDM policy & practice·2026
Same author

An international survey of undergraduate trainees' interests and expected teaching strategies in geriatric oncology.

BMC medical education·2026
Same author

Physical Function and Residential Relocation of Older Adults Living With Chronic Conditions.

Journal of applied gerontology : the official journal of the Southern Gerontological Society·2026
Same author

Gait Changes After a Mobile Health Exercise Intervention in Older Adults With Myeloid Neoplasms: Single-Arm Pilot Trial.

JMIR cancer·2026

Related Experiment Video

Updated: Dec 6, 2025

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
08:29

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

Published on: December 18, 2016

14.4K

Multimorbidity, Function, and Cognition in Aging.

Sindhuja Kadambi1, Maya Abdallah2, Kah Poh Loh1

  • 1Department of Hematology/Oncology, University of Rochester, 601 Elmwood Drive, Rochester, NY 14642, USA.

Clinics in Geriatric Medicine
|October 4, 2020
PubMed
Summary

Multimorbidity, the presence of multiple chronic diseases, poses a significant global health challenge. This study defines, measures, and examines the prevalence, mechanisms, and outcomes of multimorbidity across diverse populations.

Keywords:
AgingComorbidityConcurrent diseaseCumulative effectMultimorbidity

More Related Videos

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.8K
Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
10:13

Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach

Published on: February 14, 2014

14.0K

Related Experiment Videos

Last Updated: Dec 6, 2025

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
08:29

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

Published on: December 18, 2016

14.4K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.8K
Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
10:13

Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach

Published on: February 14, 2014

14.0K

Area of Science:

  • Gerontology
  • Public Health
  • Epidemiology

Background:

  • Multimorbidity represents a complex global health challenge, affecting diverse populations worldwide.
  • Understanding the scope and impact of multiple chronic conditions is crucial for effective healthcare.
  • Existing research highlights the need for comprehensive definitions and measurement strategies for multimorbidity.

Purpose of the Study:

  • To define multimorbidity and outline methods for its measurement.
  • To discuss the prevalence of multimorbidity across various demographic groups.
  • To examine the underlying mechanisms of disease and disability in multimorbidity and its impact on health outcomes.

Main Methods:

  • Literature review and synthesis of existing studies on multimorbidity.
  • Analysis of prevalence data across different populations.
  • Examination of etiological pathways and functional consequences.

Main Results:

  • Multimorbidity is defined as the coexistence of two or more chronic conditions.
  • Prevalence varies significantly based on age, sex, socioeconomic status, and geographic location.
  • Mechanisms involve complex interactions between diseases, leading to reduced survival and impaired function.

Conclusions:

  • Multimorbidity is a critical issue requiring tailored public health interventions.
  • Accurate measurement and understanding of prevalence are essential for resource allocation.
  • Further research into disease interactions and functional impacts is needed to improve patient outcomes.